Development and validation of high performance liquid chromatographic method for the determination of rifampicin in human plasma

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 5, 2012, Pages 362-367

  Sriram Siddhartha, T ^a   Prasanthi, B ^a   Santosh, Tata ^b   Vijaya Ratna, J ^a  

^a ANDHRA UNIVERSITY   (India)

^b Pharmaceutical Research and Development Laboratory   (India)

Author keywords

HPLC; Rifampicin; Tuberculosis

Indexed keywords

ACETONITRILE; DICHLOROMETHANE; HYDROCHLOROTHIAZIDE; POTASSIUM DIHYDROGEN PHOSPHATE; RIFAMPICIN;

ACCURACY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PH;

EID: 84870757623     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fivy Kurniwati, Syed Azar Syed Sulaiman, Syed Wasif Gillani; Study on drug-resistant tuberculosis and tuberculosis treatment on patients with drug resistant tuberculosis in chest clinic outpatient department, International Journal of Pharmacy and Pharmaceutical Sciences 2012; 4(2): 733-737.
2. S.d. Seth, Vimelesh Seth; Antituberculosis drugs and drugs for mycobacterium avium complex, Textbook of Pharmacology, 2008; 3rd edition: Chapter 77: Page X.77. Elsevier
3. Enoche Flornce Oga; Spectrophotometric determination of isoniazid in pure and pharmaceutical formulations using vanillin, International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2: 55-58.
4. Peloquin C.A., Jaresko G.S., Yong C.L., Keung A.C., Bulpitt A.E. and Jelliffe R. W; Population pharmacokinetic modeling of isoniazid, rifampicin and pyrazinamide, Antimicrobial Agents and Chemotherapy, 1997; 41: 2670-79.
5. Conte JE Jr, Lin E, Zurlinden E; Liquid chromatographic determination of Rifampicin in human plasma, bronchoalveolar lavage fluid, and alveolar cells, Journal of Chromatographic Science 2000; 38(2):72-6.
6. Peters JH, Gordon GR, Murray Jr, Ichikawa W, Gilber RH, Welch TM; Measurement of Rifampicin in plasma: chemical vs bacteriologic assay, Proceedings of the Western Pharmacology Society, 1977; 20(-HD-): 211-5.
7. J B McConnell, H Smith, M Davis, and R Williams; Plasma rifampicin assay by an improved solvent extraction technique, British Journal of Clinical Pharmacology, Nov 1979; 8 (5): 507.
8. Udupa N, Goyal P, Agarwal S, Venkatesh S, Pandey S; Simultaneous HPTLC determination of rifampicin and isoniazid in rat plasma, Indian Journal of Pharmaceutical Sciences, 2003; 65: 414-416.
9. Calleja I, Blanco-Prieto M.J., Ruz N, Renedo M.J., Dios-Vieitez M. C; High performance liquid-chromatographic determination of rifampicin in plasma and tissues, Journal of Chromatography A, 2004; 1031: 289-294.
10. Khuhawar M.Y., Rind F.M. A; Liquid chromatographic determination of isoniazid, pyrazinamide and rifampicin from pharmaceutical preparations and blood. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2002; 766: 357-363.
11. Calleri E., De Lorenzi E., Furlanetto S., Massolini G., Caccialanza G; Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation, Journal of Pharmaceutical and Biomedical Analysis, 2002; 29: 1089-1096.
12. Mohan B., Sharda N., Singh S; Evaluation of the recently reported USP gradient HPLC method for analysis of antituberculosis drugs for its ability to resolve degradation products of rifampicin, Journal of Pharmaceutical and Biomedical Analysis, 2003; 31: 607-612.
13. Walubo A., Smith P., Folb P. I; Comprehensive assay for pyrazinamide, rifampicin and isoniazid with its hydrazine metabolites in human plasma by column liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, 1994; 658: 391-396.
14. Woo J., Wong C.L., Teoh R., Chan K; Liquid chromatographic assay for the simultaneous determination of pyrazinamide and rifampicin in serum samples from patients with tuberculosis meningitis; Journal of Chromatography B: Biomedical Science and Applications 1987; 420: 73-80.
15. Ishii M. Ogata H; Determination of rifampicin and its main metabolites in human plasma by high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, 1988; 426: 412-416.
16. Seifart H.I., Kruger P.B., Parkin D.P., Van Jaarsveld P.P., Donald P. R; Therapeutic monitoring of antituberculosis drugs by direct in-line extraction on a high performance liquid chromatography system, Journal of Chromatography B: Biomedical Sciences and Applications, 1993: 619: 285-290.
17. Ratti B., Parenti R.R., Toselli A., Zerilli L. F; Quantitative assay of Rifampicin and its main metabolite 25-desacetylrifampicin in human plasma by reversed-phase high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, 1981; 225: 526-531.
18. Smith P.J., Dyk J.V., Fredericks A; Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma, International Journal of Tuberculosis and Lung Diseases, 1999; 3: S325-S328.
19. Balbao M.S., Bertucci C., Bergamaschi M.M., Queiroz R.H.C., Malfara W.R., Dreossi S.A. C; Rifampicin determination in plasma by stir bar-sorptive extraction and liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, 2010; 5: 1078-1083.
20. Gikas E., Bazoti F.N., Fanourgiakis P., Perivolioti E., Roussidis A., Skoutelis A; Simultaneous quantification of daptomycin and rifampicin in plasma by ultra performance liquid chromatography: application to a pharmacokinetic study, Journal of Chromatography B: Biomedical Sciences and Applications, 2010; 51: 901-906.
21. Hartkoorn R.C., Khoo S., Back D.J., Tjia J.F., Waitt C.J., Chaponda MA; Rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2007; 857: 76-82.
22. Korfmacher W.A., Bloom J., Churchwell M.I., Getek T.A., Hansen Jr E.B., Holder C.L., Characterization of three rifamycins via electro spray mass spectrometry and HPLC-thermo spray mass spectrometry, Journal of Chromatographic Sciences, 1993; 31: 498-501.
23. Baietto L., Avolio A., De Rosa F.G., Garazzino S., Michelazzo M., Ventimiglia G., Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma, Analytical and Bioanalytical Chemistry, 2010; 396: 791-798.
24. De Velde F., Alffenaar J.W. C, Wessels A.M.A., Greijdanus B., Uges D.R.A., Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2009; 877: 1771-1777.
25. Notari S., Mancone C., Sergi M., Gullotta F., Bevilacqua N., Tempestilli M., Determination of antituberculosis drug concentration in human plasma by MALDI-TOF/TOF, IUBMB Life, 2010; 62: 387-393.
26. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, 2001.
27. Cara Polson, Pratibha Sarkar, Bev Incledon, Vanaja Raguvaram, Russell Grant; Optimization of Protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry, Journal of Chromatography B, 2003; 785: 263-275.